ImmunityBio Inc - Common Stock — Cash Flow (NASDAQ:IBRX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -70.45 M-274.42 M-337.51 M-366.76 M-391.24 M-304.94 M -304.94 M Cash from investing activities -20.59 M-84.89 M27.3 M-30.47 M-12.25 M-149.8 M -149.8 M Cash from financing activities 86.97 M505.44 M233.61 M558.34 M281.63 M400.24 M 400.24 M Free cash flow -73.09 M-307.98 M-436.9 M-397.34 M-398.12 M-309.19 M -308.78 M

Haberler

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio’nun 1Ç geliri yıllık %168 artışla 44,2 milyon dolar

ImmunityBio, FDA’nın tanıtım uyum endişelerine yanıt verdi

ImmunityBio hisseleri FDA uyum yanıtı sonrası yükseldi

ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)

ImmunityBio hisseleri 100 milyon dolarlık anlaşmayla yükseldi

ImmunityBio 75 milyon dolar finansman sağladı

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)

ImmunityBio’nun mesane kanseri çalışması yeterli güçte bulundu

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?